Conmed (NYSE: CNMD) revenue
Conmed reported revenue of $1,375m for fiscal 2025, 5.2% more than in fiscal 2024 ($1,307m). Since fiscal 2016 its revenue has grown by 80.1%, an average growth of 6.8% a year.
Conmed has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −9.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,375m | +5.2% | $102.6m | 7.5% |
| 2024 | $1,307m | +5.0% | $200.3m | 15.3% |
| 2023 | $1,245m | +19.1% | $120.6m | 9.7% |
| 2022 | $1,045m | +3.4% | $70.1m | 6.7% |
| 2021 | $1,011m | +17.2% | $109.7m | 10.9% |
| 2020 | $862.5m | −9.7% | $46.0m | 5.3% |
| 2019 | $955.1m | +11.1% | $79.1m | 8.3% |
| 2018 | $859.6m | +7.9% | $71.3m | 8.3% |
| 2017 | $796.4m | +4.3% | $46.9m | 5.9% |
| 2016 | $763.5m | — | $37.7m | 4.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Conmed revenue compared with its sector
By revenue for its latest fiscal year, Conmed ranks 133rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Conmed, 5.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 131st | Halozyme Therapeutics | $1,397m | 37.6% |
| 132nd | LivaNova | $1,388m | 10.7% |
| 133rd | Conmed | $1,375m | 5.2% |
| 134th | Haemonetics | $1,334m | −2.0% |
| 135th | HealthEquity | $1,313m | 9.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Conmed
- How much revenue did Conmed make in fiscal 2025?
- Conmed reported revenue of $1,375m for fiscal 2025, compared with $1,307m in fiscal 2024.
- How much has the revenue of Conmed grown?
- Between fiscal 2016 and fiscal 2025 it went from $763.5m to $1,375m: 80.1% more, an average growth of 6.8% a year.
- What was the best year for revenue at Conmed?
- Of its last 10 fiscal years, fiscal 2025, with $1,375m.
- Where does Conmed rank in its sector by revenue?
- It ranks 133rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Conmed come from?
- From the annual report (Form 10-K) that Conmed files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Conmed files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Conmed: the Conmed page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Conmed by fiscal year, with the filing behind every figure: Conmed dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.